Company intelligence / Profile preview

New Zealand Urogenital

Auckland, New Zealand

Ownership: Private
Development stage: Other

Overview

New Zealand Urogenital was a biotechnology company based in New Zealand that focused on the development of treatments for urogenital conditions. The company was primarily known for its research into pharmaceutical interventions for erectile dysfunction and other related urological disorders. Despite its early efforts in the life sciences sector, the company is no longer active and has been removed from the New Zealand Companies Register. Its operations were centered on leveraging local research to address global health needs in the urogenital space.

Therapeutic areas: NephrologyMen's Health
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on New Zealand Urogenital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on New Zealand Urogenital.

Explore the full profile